Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes
Authors:
- 5 May 2020
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 146 (9) , 2379-2397
Abstract
Background We present preliminary data of the first older cancer patients treated with Hybrid Linac for stereotactic body radiotherapy (SBRT) consisting of 1.5 T MRI-guided and daily-adapted treatment. The aim was to assess feasibility, safety and the role of G8 and Charlson Comorbidity Index (CCI) questionnaires in predicting patients’ QoL, evaluated by patient-reported outcome measures (PROMs). Methods Two groups of patients with localized prostate cancer or abdominal-pelvic oligometastases were analyzed. SBRT schedule consisted of 35 Gy delivered in 5 fractions. The primary endpoint was to measure the impact of G8 and CCI on PROMs. Both G8 and the CCI were performed at baseline, while the EORTC Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) for PROMs assessment was prospectively performed at baseline and after SBRT. Results Forty older patients were analyzed. The median age was 73 years (range 65–85). For the entire population, the median G8 score was 15 (10–17) and the median CCI score was 6 (4–11). Concerning the PROMS, the EORTC-QLQ C30 questionnaire reported no difference between the pre- and post-SBRT evaluation in all patients, except for the fatigue item that declined after SBRT, especially in the group of patients with a G8 score < 15 and with age < 75 years (p = 0.049). No grade 3 or higher acute toxicity occurred. Conclusion This is the first report documenting for older cancer patients that 1.5 T MRI-guided daily-adapted SBRT is feasible, safe and does not impact on the QoL at the end of treatment. Longer follow-up is advocated to report long-term outcomes. Trial registration Date of approval April 2019 and numbered MRI/LINAC no. 23748.Keywords
This publication has 41 references indexed in Scilit:
- Cancer-related and treatment-related fatigueGynecologic Oncology, 2015
- Feasibility of radiation therapy in patients 90years of age and older: A French multicentre analysisEuropean Journal of Cancer, 2014
- Accuracy of the G-8 geriatric-oncology screening tool for identifying vulnerable elderly patients with cancer according to tumour site: The ELCAPA-02 studyJournal of Geriatric Oncology, 2014
- Performance of Two Geriatric Screening Tools in Older Patients With CancerJournal of Clinical Oncology, 2014
- Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter StudyJournal of Clinical Oncology, 2011
- Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancerRadiotherapy and Oncology, 2009
- Fatigue in cancer: A review of literatureIndian Journal of Palliative Care, 2009
- Claustrophobia during magnetic resonance imaging: Cohort study in over 55,000 patientsJournal of Magnetic Resonance Imaging, 2007
- Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2005
- Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment TrialsNew England Journal of Medicine, 1999